These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5654242)

  • 1. [Comparative assessment of immunological reactions in patients with obliterating thromboangiitis and atherosclerosis].
    Akhrem-Akhremovich RM; Ignatova LN; Shabanova IN
    Kardiologiia; 1968 Jan; 8(1):55-8. PubMed ID: 5654242
    [No Abstract]   [Full Text] [Related]  

  • 2. [Autoantibodies in arteriosclerosi and endangiitis obliterans].
    Storch W; Voigt H
    Z Gesamte Inn Med; 1979 May; 34(10):124-6. PubMed ID: 483918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular sensitivity to collagen in thromboangiitis obliterans.
    Adar R; Papa MZ; Halpern Z; Mozes M; Shoshan S; Sofer B; Zinger H; Dayan M; Mozes E
    N Engl J Med; 1983 May; 308(19):1113-6. PubMed ID: 6835334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunoglobulins in patients with arteriosclerosis & thromboangitis obliterans.
    Sooch N; Goyal A; Abbey RK; Gupta MK; Gupta RR
    Indian J Med Res; 1987 Jan; 85():49-52. PubMed ID: 3583356
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperproduction of immunoglobulin E in occlusive diseases of the peripheral arteries].
    Baranov AA; Shilkina NP; Masenko VP; Kushekbaeva AE; Nasonov EL; Lebedin IuG
    Klin Med (Mosk); 1991 Apr; 69(4):45-8. PubMed ID: 1865650
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative results of reconstructive surgery of the arteries of the femoro-popliteal-tibial segment in patients with obliterating atherosclerosis and thromboangiitis].
    Gervaziev VB; Khorev NG; Bykov VM; Fust VI; Lukovskiĭ NK; Chilikidi KIu
    Klin Khir (1962); 1989; (7):7-9. PubMed ID: 2796160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Juvenile peripheral obliterating arteriopathy. Diagnostic and etiopathogenetic problems].
    Cotti L
    Minerva Med; 1974 Jan; 65(5):249-56. PubMed ID: 4819381
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA antigens in arterial occlusive diseases in Japan.
    Ohtawa T
    Jpn J Surg; 1976 Mar; 6(1):1-8. PubMed ID: 10460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thromboangiitis and atherosclerosis obliterans: differences in location and smoking habits].
    Puchmayer V
    Cas Lek Cesk; 1984 Oct; 123(43):1312-7. PubMed ID: 6509480
    [No Abstract]   [Full Text] [Related]  

  • 10. [Relations between vascular lesions of the obliterating type and gastroduodenal ulcer].
    Cariello M
    Gazz Int Med Chir; 1965 Aug; 69(16):1313-25. PubMed ID: 5849983
    [No Abstract]   [Full Text] [Related]  

  • 11. [Descriptions of peripheral chronic obliterating arteriopathy based on parallel and comparative studies of the clinical aspects, arteriographical and histopathological data and conditions of blood coagulability].
    TAGLIACOZZO S; TONELLI L
    Arch De Vecchi Anat Patol; 1956 Jun; 24(2):443-562. PubMed ID: 13363590
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of adrenalectomy and lumbar ganglionectomy in the therapy of chronic peripheral obliterating arteriopathy (C.P.O.A.) of the lower extremities].
    Guagliano G; Vittori C; Maurizio A; Taborelli R
    Minerva Chir; 1967 Feb; 22(4):159-70. PubMed ID: 6050194
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE RESULTS OF ELECTROMYOGRAPHIC STUDIES OF OBLITERATING ARTERIAL DISEASES].
    KOWALSKA M
    Pol Arch Med Wewn; 1964; 34():1201-12. PubMed ID: 14235108
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of electromyography in angiology.
    Kozák P
    Acta Univ Carol Med Monogr; 1975; (65):5-89. PubMed ID: 180786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health-resort treatment of obliterating diseases of the peripheral vessels].
    Kents VV; Andreeva NA
    Sov Med; 1976 Apr; (4):132-7. PubMed ID: 982131
    [No Abstract]   [Full Text] [Related]  

  • 16. [Site of excision of the lumbar sympathetic trunk in the treatment of obliterating lesions of blood vessels of the lower limbs].
    Kolodziejczyk Z
    Folia Med Cracov; 1972; 14(2):253-62. PubMed ID: 5086170
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of metabolism in patients with arteriosclerosis obliterans and arteritis].
    Savel'ev VS; Koshkin VM; Chesnokova TT; Endlina OV; Baranov AP
    Kardiologiia; 1988 Sep; 28(9):35-8. PubMed ID: 3236641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of latent or manifest coronary disease in patients with peripheral obliterating arteriopathy. Clinico-statistical study of 449 cases].
    Meciani L; Ricci G; Castelli E; Basso P; Trentini R
    Minerva Cardioangiol; 1967 Dec; 15(12):813-23. PubMed ID: 5610483
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular function and circulating progenitor cells in thromboangitis obliterans (Buerger's disease) and atherosclerosis obliterans.
    Idei N; Nishioka K; Soga J; Hidaka T; Hata T; Fujii Y; Fujimura N; Maruhashi T; Mikami S; Teragawa H; Kihara Y; Noma K; Chayama K; Higashi Y
    Hypertension; 2011 Jan; 57(1):70-8. PubMed ID: 21115876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.